LLY

禮來

934.60

+83.39+9.80%
Pre Market: 939.02  +4.42  +0.47%05:21 05/01 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE971.93/967.93
TODAY RANGE964.41-985.96
VOL884.86K
MARKET CAP922.62B
52 WEEK RANGE620.46-1,132.06
AVG VOL (3M)3.11M
% TURNOVER0.09%
TURNOVER--
P/E (TTM)34.81
% RANGE2.23%
EPS(TTM)28.15
P/E(FORWARD)28.52
P/B29.63
BVPS33.07
DIVIDEND6.92
P/S14.20
BETA--
DIV YIELD0.71%
FREE FLOAT MKT CAP920.45B
SHARES OUTSTANDING941.74M
NEXT EARNINGS02/04-02/09
FREE FLOAT939.52M
LOT SIZE1
EX-DATE05/15/2026
Same Industry
Name/Symbol
Change%
Price

禮來

LLY

+9.80%
934.60

麥克森

MCK

-0.14%
814.02

生物基因

BIIB

-2.62%
189.28

安進

AMGN

+2.43%
346.25

B

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+9.07%
0.0842

沙爾製藥

SHPG

0.00%
179.20

新基醫藥

CELG

0.00%
108.24

T

Therapeuticsmd Inc

TXMD

-2.76%
2.052

強生

JNJ

-0.72%
228.19

艾伯維

ABBV

-2.23%
206.60

碩騰

ZTS

-0.70%
114.16

吉利德科學

GILD

+1.55%
130.84

N

Novo-Nordisk A/S

NVO

+5.97%
42.70

百時美施貴寶

BMY

-2.82%
58.88

亞力兄製藥

ALXN

0.00%
182.50

輝瑞製藥

PFE

+1.49%
26.65

賽諾菲

SNY

-1.07%
46.08

S

Sanofi FR

GCVRZ

0.00%
0.8711

諾華製藥

NVS

-0.86%
146.59

如瑞迪博士

RDY

-0.66%
13.64

G

GSK PLC

GSK

+1.96%
52.41

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.